Top Markets
#1 DogBull DogBull +107.30%
#2 MarsCoin MarsCoin +62.81%
#3 Siacoin Siacoin +51.84%
#4 ADO Protocol ADO Protocol +51.50%
#5 Ontology Gas Ontology Gas +24.09%
#6 The Bitcoin Bull The Bitcoin Bull +17.18%
#7 Useless Coin Useless Coin +14.86%
#8 Apertum Apertum +14.84%
#9 Nockchain Nockchain +12.03%
#10 UnifAI Network UnifAI Network +11.58%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Rang in Aktien #15300
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Aktienkurs
$6.64
Zuletzt synchronisiert: 2026-08-31
Marktkapitalisierung
$361.08M
Veränderung (1 Tag)
-0.82%
Veränderung (1 Jahr)
-61.27%
Land
US
Handel Upstream Bio, Inc. (UPB)

Kategorie

Healthcare
Kursverlauf für Upstream Bio, Inc. (UPB)
Höchster Schlusskurs: $6.99 am 2026-08-01

Niedrigster Schlusskurs: $24.44 am 2024-10-01
Kursverlauf der Aktie von Upstream Bio, Inc. von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -45.06%
2025 43.52%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.37 -11.93%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.64 5.07%
CH